Lower genetically predicted tPA levels were associated with higher risk of HT (OR, 0.57; 95% CI, 0.35–0.93; P = .023), but this result was not consistent across all sensitivity methods (Supplementary Table S8 and Supplementary Figure S1). Here, PLAT is linked to hematocrit.